Capital Advantage, Inc.
- SEC CIK
- 0001628896
- Latest filing
- Jul 13, 2026
PFE holding history
Pfizer Inc in every 13F filed by Capital Advantage, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 19
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −9,187−100.0% | Sold out | Holders |
| Q3 2025 | 9,187 | $234.1K | <0.1% | −159−1.7% | Reduced | Holders |
| Q2 2025 | 9,346 | $226.6K | <0.1% | −5,550−37.3% | Reduced | Holders |
| Q1 2025 | 14,896 | $395.2K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 14,896 | $395.2K | 0.1% | −5,404−26.6% | Reduced | Holders |
| Q3 2024 | 20,300 | $587.5K | 0.1% | −1,729−7.8% | Reduced | Holders |
| Q2 2024 | 22,029 | $615.3K | 0.1% | +16+0.1% | Added | Holders |
| Q1 2024 | 22,013 | $626.1K | 0.1% | −232−1.0% | Reduced | Holders |
| Q4 2023 | 22,245 | $640.4K | 0.1% | −2,825−11.3% | Reduced | Holders |
| Q3 2023 | 25,070 | $831.6K | 0.2% | +508+2.1% | Added | Holders |
| Q2 2023 | 24,562 | $876.4K | 0.2% | −235−0.9% | Reduced | Holders |
| Q1 2023 | 24,797 | $1.01M | 0.2% | +883+3.7% | Added | Holders |
| Q4 2022 | 23,914 | $1.23M | 0.3% | −73−0.3% | Reduced | Holders |
| Q3 2022 | 23,987 | $1.05M | 0.2% | +1,951+8.9% | Added | Holders |
| Q2 2022 | 22,036 | $1.16M | 0.3% | −797−3.5% | Reduced | Holders |
| Q1 2022 | 22,833 | $1.18M | 0.3% | +791+3.6% | Added | Holders |
| Q4 2021 | 22,042 | $1.19M | 0.3% | +506+2.3% | Added | Holders |
| Q3 2021 | 21,536 | $926.0K | 0.3% | +45+0.2% | Added | Holders |
| Q2 2021 | 21,491 | $842.0K | 0.2% | −12−0.1% | Reduced | Holders |
| Q1 2021 | 21,503 | $779.0K | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.